Investigational Site Number 840001 — Kansas City, Kansas

Investigational Site Number 840001 is a clinical research site located in Kansas City, Kansas, United States 66160-7321.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 840001 has participated in 3 clinical trials.

Therapeutic areas: Glycogen Storage Disease Type II Pompe Disease, Pompe Disease, Glycogen Storage Disease Type II (GSD II).

Sponsors: Genzyme, a Sanofi Company, Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Kansas City

Browse all research sites in Kansas · View every site in Kansas City

• University of Kansas Med Ctr; Int med/Allgy/Immun/Rheum
• University of Kansas Hospital-Hospital
• University of Kansas Medical Center; Department of Hematology
• The University of Kansas Health
• The Marc A. Asher Comprehensive Spine Center at the Kansas University Medical Center
• University of Kansas Medical center Medical office building
• University of Kansas Medical Center CBYM338B2203
• University of Kansas Health Sy /ID# 78929
• University of Kansas Medical Center Research Institute
• The University of Kansas Clinical Research Center
• University of Kansas Hospital and Medical Center
• The University of Kansas Health System

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840001?

Investigational Site Number 840001 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840001 conducted?

Investigational Site Number 840001 has 3 clinical trials on record. Their work covers Glycogen Storage Disease Type II Pompe Disease, Pompe Disease, Glycogen Storage Disease Type II (GSD II).

Is Investigational Site Number 840001 accredited by Crixeo Clinical Trials?

Investigational Site Number 840001 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840001?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.